JoVE Logo
Faculty Resource Center

Sign In

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent Video (Video) | JoVE

DOI :

10.3791/50565-v

September 3rd, 2013

September 3rd, 2013

11,067 Views

1Department of Biomedical Engineering, Case Western Reserve University , 2Department of Translational Hematology & Oncology Research, Cleveland Clinic, Case Western Reserve University , 3Department of Molecular Biology & Microbiology, Case Western Reserve University

To demonstrate MR cancer molecular imaging with a small peptide targeted MRI contrast agent specific to clotted plasma proteins in tumor stroma in a mouse prostate cancer model.

-- Views

Related Videos

article

In vivo Near Infrared Fluorescence NIRF Intravascular Molecular Imaging of Inflammatory Plaque, a Multimodal Approach to Imaging of Atherosclerosis Video (Video) | JoVE

article

Contrast Enhanced Vessel Imaging using MicroCT Video (Video) | JoVE

article

Evaluation of Nanoparticle Uptake in Tumors in Real Time Using Intravital Imaging Video (Video) | JoVE

article

Molecular Imaging to Target Transplanted Muscle Progenitor Cells Video (Video) | JoVE

article

In vivo Macrophage Imaging Using MR Targeted Contrast Agent for Longitudinal Evaluation of Septic Arthritis Video (Video) | JoVE

article

An Orthotopic Murine Model of Human Prostate Cancer Metastasis Video (Video) | JoVE

article

Isolation of Cancer Stem Cells From Human Prostate Cancer Samples Video (Video) | JoVE

article

Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts Video (Video) | JoVE

article

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model Video (Video) | JoVE

article

Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells Video (Video) | JoVE

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved